Baxter
BAX
#1132
Rank
โ‚ฌ14.65 B
Marketcap
28,57ย โ‚ฌ
Share price
-6.40%
Change (1 day)
-28.30%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

Baxter (BAX) - Total assets

Total assets on the balance sheet as of December 2024 : โ‚ฌ23.38 Billion

According to Baxter's latest financial reports the company's total assets are โ‚ฌ23.38 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Baxter - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ24.77 B-3.14%
2023-12-31โ‚ฌ25.57 B-3%
2022-12-31โ‚ฌ26.37 B-10.91%
2021-12-31โ‚ฌ29.59 B81.86%
2020-12-31โ‚ฌ16.27 B0.22%
2019-12-31โ‚ฌ16.24 B18.19%
2018-12-31โ‚ฌ13.74 B-3.64%
2017-12-31โ‚ฌ14.26 B-3.51%
2016-12-31โ‚ฌ14.77 B-22.91%
2015-12-31โ‚ฌ19.17 B-10.8%
2014-12-31โ‚ฌ21.49 B17.66%
2013-12-31โ‚ฌ18.26 B18.49%
2012-12-31โ‚ฌ15.41 B4.96%
2011-12-31โ‚ฌ14.68 B11.7%
2010-12-31โ‚ฌ13.14 B8.55%
2009-12-31โ‚ฌ12.11 B9.92%
2008-12-31โ‚ฌ11.01 B5.2%
2007-12-31โ‚ฌ10.47 B-5.89%
2006-12-31โ‚ฌ11.12 B3.6%
2005-12-31โ‚ฌ10.74 B3.02%
2004-12-31โ‚ฌ10.42 B-4.21%
2003-12-31โ‚ฌ10.88 B-8.79%
2002-12-31โ‚ฌ11.93 B1.92%
2001-12-31โ‚ฌ11.71 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
โ‚ฌ42.63 B 82.31%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ38.97 B 66.67%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ35.73 B 52.80%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ49.58 B 112.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.87 B-92.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ88.27 B 277.48%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ4.22 B-81.94%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ81.61 B 248.98%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚ฌ3.81 B-83.69%๐Ÿ‡บ๐Ÿ‡ธ USA